Hepatitis A Vaccine
- Atc Codes:J07BC02
Table of contents
- Brand Names
- Drug Combinations
- Pharmacologic Category
- Mechanism of Action
- Therapeutic Use
- Contraindications
- Warnings and Precautions
- Adverse Reactions
- Caution and personalized dose adjustment in patients with the following genotypes
- Drug Interactions
- Dosage
- Special Considerations
Brand Names
Europe
Austria: Avaxim, Epaxal, Havrix, Vaqta-K; Belgium: Epaxal; Bulgaria: Avaxim, Havrix, Vaqta; Cyprus: Avaxim, Havrix; Czech Republic: Avaxim, Havrix, Vaqta; Denmark: Epaxal, Havrix; Estonia: Avaxim, Havrix; Finland: Epaxal, Havrix; France: Avaxim, Havrix; Germany: Avaxim, Epaxal, HAV pur, Havrix, HepA-RIX, Vaqta; Greece: Avaxim, Epaxal, Havrix, Vaqta; Hungary: Avaxim, Havrix, Vaqta; Ireland: Avaxim, Epaxal, Havrix, Vaqta; Italy: Avaxim, Epaxal, Havrix, Vaqta; Latvia: Avaxim, Havrix; Lithuania: Avaxim, Havrix; Luxembourg: Avaxim, Epaxal, Havrix, Vaqta; Malta: Havrix; Netherlands: Avaxim, Epaxal, Havrix, Vaqta; Poland: Avaxim, Havrix, Vaqta; Portugal: Avaxim, Epaxal, Havrix, Vaqta; Romania: Avaxim, Havrix, Vaqta; Slovakia: Avaxim, Havrix, Vaqta; Spain: Epaxal, Havrix, Vaqta; Sweden: Avaxim, Epaxal, Havrix, Vaqta; UK: Avaxim, Epaxal, Havrix, Vaqta.
North America
Canada: Avaxim, Epaxal, Havrix, Vaqta; USA: Havrix, Vaqta.
Latin America
Argentina: Avaxim, Epaxal, Havrix, Vaqta; Mexico: Avaxim, Havrix, Vaqta.
Asia
Japan: Aimmugen.
Drug combinations
Hepatitis A Vaccine and Hepatitis B Vaccine
Hepatitis A Vaccine and Salmonella typhi
Chemistry
Pharmacologic Category
Serums, Toxoids, and Vaccines; Vaccines. (ATC-Code: J07BC02).
Mechanism of action
As an inactivated virus vaccine, hepatitis A vaccine offers active immunization against hepatitis A virus infection at an effective immune response rate in up to 99% of subjects.
Therapeutic use
Active immunization against disease caused by hepatitis A virus.
Pregnancy and lactiation implications
Unlabeled use
Contraindications
Hypersensitivity to hepatitis A vaccine or any component of the formulation.
Warnings and precautions
Anaphylactoid/hypersensitivity reactions. Use with caution in history of bleeding disorders (including thrombocytopenia) and/or patients on anticoagulant therapy. Use with caution in severely immunocompromised patients (e.g. patients receiving chemo/radiation therapy or other immunosuppressive therapy (including high dose corticosteroids)). Packaging may contain natural latex rubber. Some products may contain neomycin.